Hepatocellular Carcinoma in HIV-infected Patients (GEHEP-002)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Know the risks and potential benefits of clinical studies and talk to your health care provider before participating.
Read our disclaimer for details.
Observational study. All HIV-infected patients who have been diagnosed of hepatocellular carcinoma (HCC), following the American Association for the Study of Liver Diseases (AASLD) criteria, in the participant centers are included. Epidemiological, clinical and laboratory data are collected. The clinical and epidemiological characteristics of HCC cases will be analyzed. The efficacy and outcomes after modalities of HCC therapy will be assessed. Mortality and its predictors will be also assessed. In those cases infected by hepatitis C virus (HCV), the impact of HCV therapy on outcomes will be analysed.
Condition or disease
Hepatocellular CarcinomaHIVChronic Hepatitis CHepatitis B VirusLiver Cirrhosis
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
HIV-infected patients who are diagnosed of hepatocellular carcinoma following AASLD criteria.
Diagnosis of hepatocellular carcinoma according to American Association for the Study of Liver Diseases (AASLD) criteria
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD:
Additional relevant MeSH terms:
Layout table for MeSH terms
Hepatitis C, Chronic
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Digestive System Diseases
Hepatitis, Viral, Human
RNA Virus Infections
Digestive System Neoplasms
Neoplasms by Site
DNA Virus Infections